Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

"Our aim is to provide pharmaceutical companies and clinical researchers with scalable, high-throughput tools for oncology drug discovery." Okomera's platform integrates automated organoid ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...

Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

ROCHESTER, Minnesota — Mayo Clinic researchers have developed  organoid models  to study  uveal melanoma , one of the most common types of eye cancer ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...